9.15  0.01 (0.11%)		06-15 09:32
Open: 9.08 High: 9.17 Volume: 6,095		Pre. Close: 9.14 Low: 9.08 Market Cap: 185(M)

Short term
Mid term
Targets	6-month :	11.96	1-year :	13.96
Resists	First :	10.23	Second :	11.96
Pivot price	9.12
Supports	First :	8.88	Second :	8.03
MAs	MA(5) :	9.01	MA(20) :	9.21
	MA(100) :	9.14	MA(250) :	8.9
MACD	MACD :	-0.2	Signal :	-0.2
%K %D	K(14,3) :	18.3	D(3) :	16.5
RSI	RSI(14): 48.2
52-week	High :	11.03	Low :	5.38

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ INFU ] has closed below upper band by 48.1%. Bollinger Bands are 49.5% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 0 bars. This is a sign that the market may be about to initiate a new trend.

If tomorrow:	Open lower	Open higher
High:	9.28 - 9.32	9.32 - 9.36
Low:	8.92 - 8.96	8.96 - 9
Close:	9.07 - 9.14	9.14 - 9.2

InfuSystem Holdings, Inc. delivers infusion pumps, along with associated products and support services, to clients across the United States and Canada. The enterprise operates through two principal divisions: Integrated Therapy Services (ITS) and Durable Medical Equipment Services (DME Services). The ITS segment specializes in providing electronic ambulatory infusion devices and accompanying disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy facilities. These devices are crucial for managing various cancers, including colorectal cancer, as well as for pain management and other therapeutic needs. Moreover, the company markets, leases, and rents out a selection of new and pre-owned infusion pumps (both pole-mounted and ambulatory) and other vital durable medical equipment. It also sells consumables essential for treatment. InfuSystem further extends its offerings to include biomedical recertification, maintenance, and repair services for oncology practices and diverse alternative care settings, such as home care and home infusion providers, skilled nursing facilities, pain centers, and hospitals. Additionally, InfuSystem furnishes both local and field-based customer assistance and manages dedicated pump service and repair facilities. The company was founded in 2005 and maintains its corporate headquarters in Rochester Hills, Michigan.

Mon, 18 May 2026
InfuSystem (INFU) Board approves new $20 million share repurchase program - Stock Titan

Mon, 18 May 2026
InfuSystem Announces $20M Buyback Plan Through June 2028 - TradingView

Mon, 18 May 2026
InfuSystem Announces $20 Million Stock Repurchase Program - Business Wire

Thu, 14 May 2026
InfuSystem Holdings, Inc. Appoints Beverly Huss as the Chairman of the Board of Directors - marketscreener.com

Thu, 07 May 2026
Earnings call transcript: InfuSystems Q1 2026 beats EPS forecast, stock drops - Investing.com

Thu, 07 May 2026
Revenue slips, profit returns as InfuSystem sticks to 2026 outlook - Stock Titan

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Outperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: AMEX
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.